MXPA03010633A - Metodo para trastornos de resequedad de ojos. - Google Patents

Metodo para trastornos de resequedad de ojos.

Info

Publication number
MXPA03010633A
MXPA03010633A MXPA03010633A MXPA03010633A MXPA03010633A MX PA03010633 A MXPA03010633 A MX PA03010633A MX PA03010633 A MXPA03010633 A MX PA03010633A MX PA03010633 A MXPA03010633 A MX PA03010633A MX PA03010633 A MXPA03010633 A MX PA03010633A
Authority
MX
Mexico
Prior art keywords
dry eye
treating dry
eye disorders
beta
alpha
Prior art date
Application number
MXPA03010633A
Other languages
English (en)
Inventor
M Yanni John
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of MXPA03010633A publication Critical patent/MXPA03010633A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Abstract

22, 29-epoxi-3, 4, 6, 7, 29-pentahidroxi-, (3a, 4¦, 5a, 6a, 7¦, 14¦, 22S)-stigmastan-15-ona es util para tratar trastornos de resequedad de ojos y otros trastornos que requieren la humectacion del ojo.
MXPA03010633A 2001-05-21 2003-11-19 Metodo para trastornos de resequedad de ojos. MXPA03010633A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29250001P 2001-05-21 2001-05-21

Publications (1)

Publication Number Publication Date
MXPA03010633A true MXPA03010633A (es) 2004-03-09

Family

ID=23124938

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010633A MXPA03010633A (es) 2001-05-21 2003-11-19 Metodo para trastornos de resequedad de ojos.

Country Status (10)

Country Link
US (1) US20030008853A1 (es)
EP (1) EP1392322A1 (es)
JP (1) JP2004531560A (es)
CN (1) CN1239161C (es)
BR (1) BR0209882A (es)
CA (1) CA2447918A1 (es)
MX (1) MXPA03010633A (es)
PL (1) PL367097A1 (es)
WO (1) WO2002094284A1 (es)
ZA (1) ZA200308770B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094836A2 (en) 2004-03-25 2005-10-13 Bausch & Lomb Incorporated Use of loteprednol etabonate for the treatment of dry eye
WO2007137129A2 (en) * 2006-05-19 2007-11-29 Alcon Research, Ltd. RNAI-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR α-RELATED CONDITIONS
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US527851A (en) * 1894-10-23 Process of reducing aluminium
US3991759A (en) * 1975-10-28 1976-11-16 Alza Corporation Method and therapeutic system for treating aqueous deficient dry eye
US4131651A (en) * 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4370325A (en) * 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4744980A (en) * 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US4818537A (en) * 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
US5583150A (en) * 1989-08-18 1996-12-10 Alcon Laboratories, Inc. 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
ZA912797B (en) * 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
ATE132366T1 (de) * 1990-05-29 1996-01-15 Boston Ocular Res Zusammensetzung zur behandlung von dry eye erkrankungen
ATE141502T1 (de) * 1991-01-15 1996-09-15 Alcon Lab Inc Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
US6107289A (en) * 1992-04-21 2000-08-22 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β
US5958912A (en) * 1992-04-21 1999-09-28 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β
CA2133966C (en) * 1992-04-21 1997-09-09 David A. Sullivan Ocular androgen therapy in sjogren's syndrome
US5506221A (en) * 1992-12-24 1996-04-09 University Of British Columbia Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agents
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
US6046185A (en) * 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
AU2792997A (en) * 1997-05-26 1998-12-30 New Vision Co., Ltd. Medicinal compositions for topical administration containing vitamin d and vitamin k
US6096733A (en) * 1998-12-10 2000-08-01 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
EP1379540A4 (en) * 2001-04-19 2005-11-16 Bristol Myers Squibb Co POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH NF-KB PATH
US20040076691A1 (en) * 2002-01-16 2004-04-22 David Haines Anti-inflammatory formulations

Also Published As

Publication number Publication date
CN1239161C (zh) 2006-02-01
CA2447918A1 (en) 2002-11-28
EP1392322A1 (en) 2004-03-03
US20030008853A1 (en) 2003-01-09
CN1509177A (zh) 2004-06-30
WO2002094284A1 (en) 2002-11-28
BR0209882A (pt) 2004-06-08
PL367097A1 (en) 2005-02-21
JP2004531560A (ja) 2004-10-14
ZA200308770B (en) 2004-11-23

Similar Documents

Publication Publication Date Title
BR9506305A (pt) Aparelho e processo para preparação de formas sólidas com desprendimento controlado do ingrediente ativo
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
ITMI912296A0 (it) Nuovi pregna 1,4-diene-3,20.dione-16,17-acetal-21-esteri, procedimento per la loro preparazione, composizione e metodi per il trattamento di stati infiammatori
HUP9900163A3 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
HK1038693A1 (zh) 治療眼、耳、鼻病症的抗生素合成劑
IL141957A0 (en) 5ht1 receptor agonists and metoclopramide for the treatment of migraine
PL371464A1 (en) 3-alkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and 3,3'-dialkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and processes for making them
MXPA03009527A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE INDENOS 1,3-SUSTITUIDOS Y COMPUESTOS AZAPOLICICLICOS CONDENSADOS CON ARILO.
EP1016700A4 (en) WATER AND OIL REPELLENT COMPOSITION DISPERSED IN WATER AND METHOD FOR THE PRODUCTION THEREOF
HK1038694A1 (zh) 治療眼、耳、鼻病症的抗生素合成劑
HK1038692A1 (zh) 治療眼、耳、鼻病症的抗生素合成劑
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
PL367287A1 (en) Use of proteasome inhibitors to treat dry eye disorders
CA2347863A1 (en) Treatment of disorders of the outer retina
EP1383529A4 (en) METHOD FOR THE TREATMENT OF EYES AND SQUATING TISSUES WITH THYMOSINE 4 (T 4), ANALOGUE, ISOFORMS AND OTHER DERIVATIVES
EP0681787A3 (en) Use of an enzyme for the manufacture of an agent suitable for the treatment and / or prophylaxis of coccidiosis.
HU9902097D0 (en) Method for treating glaucoma
MXPA03010633A (es) Metodo para trastornos de resequedad de ojos.
AU2600299A (en) Compositions and methods of treating keratin-related disorders and conditions
PL331882A1 (en) Substituted 1,2,3,4-tetrahydro-2-dibenzofurane amines and 2-amino cyclohepta[b]benzofuranes
ES2166800T3 (es) Procedimiento para la preparacion de o,s-acetales de 2,2-difluoroceteno sililo y o,s-esteres del acido alfa,alfa-difluoro-beta-sililoxi-1,3-dioxolan-4-propanoico.
MY105555A (en) Heterocyclicguanidines as 5ht 3 antagonists.
GB9916729D0 (en) Fuller for the treatment of leather,pelts and the like
EP0852503A4 (en) AGENTS FOR THE TREATMENT OF DIARRHÖ, THEIR USE AND PRODUCTION
ZA200005540B (en) New hydroxyindoles, their use as phosphodiestrase 4 inhibitors and method for producing same.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal